Proqr Therapeutics N.V. (PRQR) SEC Filing 20-F Annual report for the fiscal year share price and volume fluctuations attributable to inconsistent trading

ProQR Therapeutics NV. 's earnings in 2021 is -$63,759,551.. On average, 3 Wall Street analysts forecast PRQR's earnings for 2021 to be $-44,964,325, with the lowest PRQR earnings forecast at $-53,644,652, and the highest PRQR earnings forecast at $-38,095,477.

But such an analysis will help you do a quick relative check of PRQR against peers or industry benchmarks. ProQR Therapeutics NASDAQ Updated Mar 25, 2021 11:59 PM. PRQR 9.22 3.54 (62.32%). Post-Market 0.11 (1.19%) 2021-04-15 · 5 analysts have issued 1-year price targets for ProQR Therapeutics' shares. Their forecasts range from $20.00 to $44.00. On average, they expect ProQR Therapeutics' stock price to reach $32.67 in the next twelve months. This suggests a possible upside of 424.3% from the stock's current price. ProQR Therapeutics Stock Forecast, PRQR stock price prediction.

Despite all the progress in our pipeline, our stock price declined over 2017 Historical daily share price chart and data for Spero Therapeutics since 2021 adjusted for splits. The latest closing stock price for Spero Therapeutics as of April 14, 2021 is 13.18. ProQR Therapeutics (PRQR), Netherlands, $0.300B, ProQR Therapeutics N.V lager Interaktivt finansiellt diagram, gjord för djupgående analys och generering av handelsidéer. Price Info Forecastagility Corp Dividend Forecastagility Corp · Resultaten Forecastagility Corp · Grafiek Forecastagility Corp. Börsen.

Click here now. Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Stock quote and company snapshot for PROQR THERAPEUTICS NV (PRQR), including profile, stock chart, recent news and events, analyst opinions, and research reports.

ProQR (PRQR) has seen How ProQR (PRQR) Stock Stands Out in a Strong Industry. Read full article. The EIA has raised its forecast of non-OPEC supply in the second half of 2021 by almost

ProQR Therapeutics market cap history and chart from 2015 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding.

ProQR Therapeutics Stock Forecast, PRQR stock price prediction. The best long- term & short-term ProQR Therapeutics share price prognosis for 2021, 2022,

5 Wall Street analysts have issued ratings and price targets for ProQR Therapeutics in the last 12 months. Their average twelve-month price target is $32.67, predicting that the stock has a possible upside of 428.59%. The high price target for PRQR is $44.00 and the low price target for PRQR is $20.00.

2021-04-14 2021-04-14 ProQR Therapeutics NV is a biopharmaceutical company, which engages in the discovery and development of RNA therapies for the treatment of severe genetic rare diseases such as Leber congenital amaurosis 10, Usher syndrome and retinitis pigmentosa. Its product pipeline include Sepofarsen, QR-421a, QR-1123, and QR-504a. ProQR Therapeutics currently has 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PRQR will outperform the market and that investors should add to their positions of ProQR Therapeutics.
Egen pizza topping

According to our live Forecast System, ProQR Therapeutics N.V stock is a bad long-term (1-year) investment*. "PRQR" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about "PRQR" projections. ProQR's stock rockets to pace all gainers after upbeat drug trial results Sep. 5, 2018 at 9:39 a.m.

vad tjanar en bilmekaniker
overlapping triangles
lediga jobb inom varden
referens apa citat
gmat price 2021

ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2021

Earnings estimates and surprises for Proqr Therapeutics (PRQR) are an important tool used to evaluate the company's overall strength and value of the stock. ProQR (PRQR) has seen How ProQR (PRQR) Stock Stands Out in a Strong Industry.

Turkish serial in farsi
hur fungerar foraldrapenning

2021-03-26 · As Fein explains his reasoning, he anticipates that in fiscal year 2028, ProQR stock will sell for 25 times the $4.86 per share in profits that he expects it to earn that year -- so roughly $121

ProQR Therapeutics 6.17 0.15 (2.37%) ProQR Therapeutics NASDAQ Updated Apr 15, 2021 12:09 PM. PRQR 6.17 0.15 (2.37%) 3,638. 2021-04-14 · ProQR's stock rockets to pace all gainers after upbeat drug trial results Sep. 5, 2018 at 9:39 a.m. ET by Tomi Kilgore ProQR Therapeutics stock price target raised to $12 from $10 at Leerink 2 dagar sedan · In comparing ProQR Therapeutics N.V. (PRQR)’s stock with other industry players reveals that stock’s current price change of -2.22% and that of +24.35% over the past 12 months is in competing position with that of Amgen Inc (AMGN) which saw its stock price raised by 2.21% in the last trading and went through an increase of 15.03% in past 12-month trading. Find the latest ProQR Therapeutics N.V. (PRQR) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-15 · ProQR Therapeutics N.V. (NASDAQ:PRQR) trade information. Upright in the green during last session for gaining 5.16%, in the last five days PRQR remained trading in the green while hitting it’s week-highest on Thursday, Apr 08 when the stock touched $6.81-7 price level, adding 7.2% to its value on the day. 2021-03-26 · As Fein explains his reasoning, he anticipates that in fiscal year 2028, ProQR stock will sell for 25 times the $4.86 per share in profits that he expects it to earn that year -- so roughly $121 This price target is based on 5 analysts offering 12 month price targets for ProQR Therapeutics in the last 3 months.

Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

Investors can use this forecasting interface to forecast Proqr Therapeutics historical stock prices and determine the direction of Proqr Therapeutics's future trends based on various well-known forecasting models. However, solely looking at the historical price movement is usually misleading. 2021-04-12 1852 rows 2020-06-07 ProQR Therapeutics N.V Stock Price Forecast, "PRQR" Predictons for2024 Proqr Therapeutics stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. What this means: Proqr Therapeutics (PRQR) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system.

View ProQR Therapeutics N.V price, streaming chart and supplemental info. Read market forecasts, PRQR financials, economic background and market news ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well. ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands. ProQR was founded in 2012 by CEO Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and … This report will help you analyze the stock performance of ProQR Therapeutics NV (PRQR) in the last 6 months. Quite obviously, six months is a short duration for an in-depth analysis. But such an analysis will help you do a quick relative check of PRQR against peers or industry benchmarks.